Structure of Lys05
CAS No.: 1391426-24-6
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Lys05 is water soluble salt of Lys01. Lys05 shows potent antitumor activity as a single agent both in vitro and in vivo in multiple human cancer cell lines and xenograft models.
Synonyms: Lys01 trihydrochloride; Lys01; Lys05 (hydrochloride)
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 1391426-24-6 |
Formula : | C23H26Cl5N5 |
M.W : | 549.75 |
SMILES Code : | CN(CCNC1=CC=NC2=CC(Cl)=CC=C12)CCNC3=CC=NC4=CC(Cl)=CC=C34.[H]Cl.[H]Cl.[H]Cl |
Synonyms : |
Lys01 trihydrochloride; Lys01; Lys05 (hydrochloride)
|
MDL No. : | MFCD28963913 |
InChI Key : | JTUYDBHQGOZPQQ-UHFFFAOYSA-N |
Pubchem ID : | 70673566 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P280-P301+P312-P302+P352-P305+P351+P338 |
Target |
|
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
MCF-7 cells | 12.3 ± 0.7 µM | 24 hours | Evaluate antiproliferative activity, results showed BAQ12 and BAQ13 had ~3-fold higher potency than Lys05 | Nat Commun. 2020 Sep 15;11(1):4615 |
HEL cells | 5 µM | Lys05 reduced HEL cell number independently of ruxolitinib inhibition. | Blood Cancer J. 2023 Jul 10;13(1):106 | |
H460 cells | 11.1 ± 0.6 µM | 24 hours | Evaluate antiproliferative activity, results showed BAQ12 and BAQ13 had ~3-fold higher potency than Lys05 | Nat Commun. 2020 Sep 15;11(1):4615 |
HT29 cells | 10.6 ± 3.4 µM | 24 hours | Evaluate antiproliferative activity, results showed BAQ12 and BAQ13 had ~3-fold higher potency than Lys05 | Nat Commun. 2020 Sep 15;11(1):4615 |
BXPC-3 cells | 7.8 ± 0.9 µM | 24 hours | Evaluate antiproliferative activity, results showed BAQ12 and BAQ13 had ~3-fold higher potency than Lys05 | Nat Commun. 2020 Sep 15;11(1):4615 |
PANC-1 cells | 13.3 ± 2.0 µM | 24 hours | Evaluate antiproliferative activity, results showed BAQ12 and BAQ13 had ~3-fold higher potency than Lys05 | Nat Commun. 2020 Sep 15;11(1):4615 |
MIA PaCa-2 cells | 16.7± 4.7 µM | 24 hours | Evaluate antiproliferative activity, results showed BAQ12 and BAQ13 had ~3-fold higher potency than Lys05 | Nat Commun. 2020 Sep 15;11(1):4615 |
A375P cells | 0 – 1000 nM | 2 weeks | To evaluate the effect of Lys05 on long-term clonogenic growth, results showed that Lys05 significantly suppressed long-term clonogenic growth of melanoma cells. | Cancer Discov. 2019 Feb;9(2):220-229 |
A375P cells | 3 μM | 6 hours | To evaluate the effect of Lys05 on lysosomal membrane permeabilization, results showed that Lys05 treatment increased lysosomal membrane permeabilization. | Cancer Discov. 2019 Feb;9(2):220-229 |
MDA-MB-231 cells | 20 μM | 72 hours | Evaluate Lys05's effect on pro-inflammatory cytokine expression; significantly increased Cxcl9, Cxcl10, Ccl5, Ifna, and Ifnb expression | Autophagy. 2024 Mar;20(3):525-540 |
Yumm 2.1 CTNNB1 | 1, 3, 5, 10μM | 16-24 hours | To assess the sensitivity of Lys05 in β-catenin-stabilized melanoma cells | Cancer Res. 2017 Nov 1;77(21):5873-5885 |
Yumm 1.7 overexpressing WNT5A | 1, 3, 5, 10μM | 16-24 hours | To assess the sensitivity of Lys05 in Wnt5A-high and β-catenin-low melanoma cells | Cancer Res. 2017 Nov 1;77(21):5873-5885 |
Yumm 1.7 | 1, 3, 5, 10μM | 16-24 hours | To assess the sensitivity of Lys05 in Wnt5A-low and β-catenin-high melanoma cells | Cancer Res. 2017 Nov 1;77(21):5873-5885 |
WM164 | 1, 3, 5, 10μM | 16-24 hours | To assess the sensitivity of Lys05 in Wnt5A-low and β-catenin-high melanoma cells | Cancer Res. 2017 Nov 1;77(21):5873-5885 |
FS13 | 1, 3, 5, 10μM | 16-24 hours | To assess the sensitivity of Lys05 in Wnt5A-high and low β-catenin melanoma cells | Cancer Res. 2017 Nov 1;77(21):5873-5885 |
HL-60 cells | 5 µM | Lys05 modified neither the response of JAK2 WT HL-60 cells to ruxolitinib. | Blood Cancer J. 2023 Jul 10;13(1):106 | |
SET-2 cells | 5 µM | Lys05 strongly enhanced the cytotoxic effects of ruxolitinib in JAK2V617F cell lines. | Blood Cancer J. 2023 Jul 10;13(1):106 | |
K562 cells expressing mRFP-GFP-LC3 | 10 µM | 4 hours | To evaluate the inhibitory effect of Lys05 on autophagy flux, results showed that Lys05 treatment led to a significant accumulation of yellow fluorescence, indicating a complete block in autophagy flow. | Leukemia. 2019 Apr;33(4):981-994 |
K562 cells | 1 µM and 10 µM | 4 hours | To evaluate the inhibitory effect of Lys05 on autophagy, results showed that Lys05 at 1 µM and 10 µM concentrations significantly increased the level of membrane-bound LC3B-II, indicating increased accumulation of autophagosomes. | Leukemia. 2019 Apr;33(4):981-994 |
CD34+ CML cells | 5 µM | To evaluate the inhibitory effect of Lys05 on autophagy, results showed that Lys05 treatment led to accumulation of LC3 puncta and increased levels of autophagy substrates SQSTM1/p62, NBR1, and NCOA4. | Leukemia. 2019 Apr;33(4):981-994 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
NSG mice | HT29 colorectal cancer xenograft model | Intraperitoneal injection | 10 mg/kg | Two daily doses | To evaluate the effect of Lys05 on tumor growth, results showed that two doses of Lys05 had only a transient effect on tumor growth. | Cancer Discov. 2019 Feb;9(2):220-229 |
Mice | Melanoma xenograft models and colon cancer xenograft model | Intraperitoneal injection | 10 mg/kg to 80 mg/kg | Daily dosing or intermittent high-dose administration | Lys05 significantly blocks autophagy in vivo and exhibits single-agent antitumor activity. Compared to HCQ, Lys05 more effectively accumulates in and deacidifies lysosomes, leading to sustained autophagy inhibition and tumor growth suppression. High-dose Lys05 causes Paneth cell dysfunction and intestinal toxicity in mice. | Autophagy. 2012 Sep;8(9):1383-4 |
FVB mice | Transplanted PyMT-driven mammary tumor model | Intraperitoneal injection | 50 mg/kg | Once daily for one week | Assess Lys05's impact on CD8+ T cell infiltration; significantly increased CD8+ T cell infiltration in tumors | Autophagy. 2024 Mar;20(3):525-540 |
Mice | Yumm 1.7, Yumm 1.7 overexpressing WNT5A, Yumm 2.1 CTNNB1 melanoma model | Intraperitoneal injection | 20mg/kg | Once daily for 14 days | To evaluate the inhibitory effect of Lys05 on melanoma tumor growth with different Wnt status | Cancer Res. 2017 Nov 1;77(21):5873-5885 |
NSG mice | HEL cell xenograft model | Intraperitoneal injection | 32 mg/kg | Daily for 14 days | Lys05 improved the response to ruxolitinib and significantly prolonged the mice's overall survival. | Blood Cancer J. 2023 Jul 10;13(1):106 |
Nude mice | C8161 xenograft | Intraperitoneal injection | 76 mg/kg | Once daily for 48 hours | Evaluate the in vivo autophagy inhibition and antitumor efficacy of Lys05. Results showed Lys05 significantly increased AV number and inhibited tumor growth. | Proc Natl Acad Sci U S A. 2012 May 22;109(21):8253-8 |
Wistar rats | HCC model | Intra-arterial administration | 40 mg/kg | Single dose | Combination therapy coupling autophagy inhibition and TAE in a rat model of HCC resulted in a 21% increase in tumor necrosis compared with TAE alone | Radiology. 2017 Jun;283(3):702-710 |
Mice | Scl-tTa-BCR-ABL/GFP-LC3 mouse model | 20 mg/kg/day | 2 days or 7 days | To evaluate the inhibitory effect of Lys05 on autophagy, results showed that Lys05 treatment led to increased GFP-LC3 levels and accumulation of SQSTM1/p62, indicating autophagy inhibition. Additionally, Lys05 treatment reduced the number of LT-HSCs and promoted expansion of MPP and LSK cells. | Leukemia. 2019 Apr;33(4):981-994 |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.82mL 0.36mL 0.18mL |
9.10mL 1.82mL 0.91mL |
18.19mL 3.64mL 1.82mL |
Tags: Lys05 | Lys01 trihydrochloride | Lys 05 | Lys-05 | Autophagy | inhibitor | 1391426-24-6 |
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL